Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood–brain barrier

Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders

Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969 · see citing works

Blood–brain barrier delivery

Pardridge, W. M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.013 · Cited by 1,191 · see citing works

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

Bu, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2620 · Cited by 1,168 · see citing works

Astroglial networks: a step further in neuroglial and gliovascular interactions

Giaume, C., Koulakoff, A., Roux, L., Holcman, D., & Rouach, N. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2757 · Cited by 781 · see citing works

Cord-Blood Transplants from Unrelated Donors in Patients with Hurler's Syndrome

Staba, S. L., Escolar, M. L., Poe, M. D., Kim, Y., Martin, P., Szabolcs, P., Allison-Thacker, J., Wood, S. J., Wenger, D. A., Rubinstein, P., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032613 · Cited by 475 · see citing works

Drug and gene targeting to the brain with molecular trojan horses

Pardridge, W. M. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd725 · Cited by 439 · see citing works

Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.

Hui, D. Y., Innerarity, T. L., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69254-9 · Cited by 383 · see citing works

Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome

Peters, C., Balthazor, M., Shapiro, E., King, R., Kollman, C., Hegland, J., Henslee-Downey, J. P., Trigg, M. E., Cowan, M. J., Sanders, J. E., et al. (1996) · Blood · doi:10.1182/blood.v87.11.4894.bloodjournal87114894 · Cited by 315 · see citing works

Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain

Kreuter, J., Hekmatara, T., Dreis, S., Vogel, T., Gelperina, S. E., & Langer, K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.012 · Cited by 263 · see citing works

Targeted delivery of proteins across the blood–brain barrier

Spencer, B. J., & Verma, I. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702170104 · Cited by 239 · see citing works

Gene therapy progress and prospects: Hydrodynamic gene delivery

Herweijer, H., & Wolff, J. A. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302891 · Cited by 189 · see citing works

Recent Advances in Blood–Brain Barrier Disruption as a CNS Delivery Strategy

Bellavance, M., Blanchette, M., & Fortin, D. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9018-7 · Cited by 183 · see citing works

Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier

Urayama, A., Grubb, J. H., Sly, W. S., & Banks, W. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405042101 · Cited by 165 · see citing works

Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier

Pan, W., Kastin, A. J., Zankel, T. R., van Kerkhof, P., Terasaki, T., & Bu, G. (2004) · Journal of Cell Science · doi:10.1242/jcs.01381 · Cited by 153 · see citing works

Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood‐brain barrier

Boado, R. J., Zhang, Y., Zhang, Y., Xia, C., Wang, Y., & Pardridge, W. M. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21602 · Cited by 142 · see citing works

An Apolipoprotein E-Derived Peptide Mediates Uptake of Sterically Stabilized Liposomes into Brain Capillary Endothelial Cells

Sauer, I., Dunay, I. R., Weisgraber, K. H., Bienert, M., & Dathe, M. (2005) · Biochemistry · doi:10.1021/bi048080x · Cited by 110 · see citing works

Strategies to Improve Drug Delivery Across the Blood-Brain Barrier

de Boer, A. G., & Gaillard, P. J. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746070-00002 · Cited by 104 · see citing works

Transporters in the Brain Endothelial Barrier

Ueno, M., Nakagawa, T., Wu, B., Onodera, M., Huang, C.-L., Kusaka, T., Araki, N., & Sakamoto, H. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790827816 · Cited by 100 · see citing works

New Prospects for the Treatment of Lysosomal Storage Diseases

Schiffmann, R., & Brady, R. O. (2002) · Drugs · doi:10.2165/00003495-200262050-00002 · Cited by 98 · see citing works

The Receptor‐Binding Region of Human Apolipoprotein E Has Direct Anti‐Infective Activity

Dobson, C. B., Sales, S. D., Hoggard, P. G., Wozniak, M. A., & Crutcher, K. A. (2006) · The Journal of Infectious Diseases · doi:10.1086/499280 · Cited by 92 · see citing works

Two Apolipoprotein E Mimetic Peptides, ApoE(130−149) and ApoE(141−155)2, Bind to LRP1

Croy, J. E., Brandon, T., & Komives, E. A. (2004) · Biochemistry · doi:10.1021/bi036208p · Cited by 90 · see citing works

The Blood-Brain Barrier and Brain Drug Delivery

Koziara, J. M., Lockman, P. R., Allen, D. D., & Mumper, R. J. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.441 · Cited by 86 · see citing works

High-Level Factor VIII Gene Expression In Vivo Achieved by Nonviral Liver-Specific Gene Therapy Vectors

Miao, C. H., Ye, X., & Thompson, A. R. (2003) · Human Gene Therapy · doi:10.1089/104303403322319381 · Cited by 84 · see citing works

Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow

Zheng, Y. W., Rozengurt, N., Ryazantsev, S., Kohn, D. B., Satake, N., & Neufeld, E. F. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00116-1 · Cited by 84 · see citing works

Reversal of Lysosomal Storage in Brain of Adult MPS-I Mice with Intravenous Trojan Horse-Iduronidase Fusion Protein

Boado, R. J., Hui, E. K., Lu, J. Z., Zhou, Q.-H., & Pardridge, W. M. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200136x · Cited by 73 · see citing works

Progression of multiple behavioral deficits with various ages of onset in a murine model of Hurler syndrome

Pan, D., Sciascia, A., Vorhees, C. V., & Williams, M. T. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.036 · Cited by 60 · see citing works

Apolipoprotein E Receptor Binding VersusHeparan Sulfate Proteoglycan Binding in Its Regulation of Smooth Muscle Cell Migration and Proliferation

Swertfeger, D. K., & Hui, D. Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102357200 · Cited by 59 · see citing works

Enzyme replacement therapy: from concept to clinical practice

Sly, W. S. (2002) · Acta Paediatrica · doi:10.1080/080352502762457978 · Cited by 57 · see citing works

Reprogramming erythroid cells for lysosomal enzyme production leads to visceral and CNS cross-correction in mice with Hurler syndrome

Wang, D., Zhang, W., Kalfa, T. A., Grabowski, G. A., Davies, S. M., Malik, P., & Pan, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908528106 · Cited by 51 · see citing works

In Vivo Gene Transfer into Adult Stem Cells in Unconditioned Mice by in Situ Delivery of a Lentiviral Vector

Worsham, D. N., Schuesler, T., Kalle, C. V., & Pan, D. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.014 · Cited by 43 · see citing works

Expression and regulation of human low-density lipoprotein receptors in Chinese hamster ovary cells

Sege, R. D., Kozarsky, K., Nelson, D. L., & Krieger, M. (1984) · Nature · doi:10.1038/307742a0 · Cited by 41 · see citing works

Laronidase (Aldurazyme®): enzyme replacement therapy for mucopolysaccharidosis type I

Pastores, G. M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.7.1003 · Cited by 27 · see citing works

Secreted Luciferase for In Vivo Evaluation of Systemic Protein Delivery in Mice

El‐Amouri, S. S., Cao, P., Miao, C. H., & Pan, D. (2012) · Molecular Biotechnology · doi:10.1007/s12033-012-9519-6 · Cited by 21 · see citing works

Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I

Pan, D., Aronovich, E. L., McIvor, R. S., & Whitley, C. B. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301298 · Cited by 18 · see citing works

Cell-and Gene-based Therapeutic Approaches for Neurological Deficits in Mucopolysaccharidoses

Pan, D. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795542679 · Cited by 13 · see citing works

Co‐expression of MGMTP140K and α‐ L ‐iduronidase in primary hepatocytes from mucopolysaccharidosis type I mice enables efficient selection with metabolic correction

Wang, D., Worsham, D. N., & Pan, D. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1141 · Cited by 7 · see citing works

Strategies for delivering therapeutics across the blood–brain barrier

Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138 · see citing works

Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle

Niewoehner, J., Bohrmann, B., Collin, L., Urich, E., Sade, H., Maier, P., Rueger, P., Stracke, J. O., Lau, W., Tissot, A. C., et al. (2014) · Neuron · doi:10.1016/j.neuron.2013.10.061 · Cited by 622 · see citing works

Nanobodies as therapeutics: big opportunities for small antibodies

Steeland, S., Vandenbroucke, R. E., & Libert, C. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.04.003 · Cited by 462 · see citing works

Blood–brain barrier shuttle peptides: an emerging paradigm for brain delivery

Oller‐Salvia, B., Sánchez‐Navarro, M., Giralt, E., & Teixidò, M. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00076b · Cited by 443 · see citing works

Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier

Lajoie, J. M., & Shusta, E. V. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124852 · Cited by 399 · see citing works

Brain-targeted drug delivery by manipulating protein corona functions

Zhang, Z., Guan, J., Jiang, Z., Yang, Y., Liu, J., Hua, W., Mao, Y., Li, C., Lu, W., Qian, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11593-z · Cited by 334 · see citing works

Overcoming the Blood–Brain Barrier. Challenges and Tricks for CNS Drug Delivery

Bors, L. A., & Erdő, F. (2019) · Scientia Pharmaceutica · doi:10.3390/scipharm87010006 · Cited by 255 · see citing works

Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis

Huang, J., Jiang, G., Song, Q., Gu, X. Q., Meng, H., Wang, X.-L., Song, H., Chen, L., Lin, Y., Jiang, D. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15144 · Cited by 211 · see citing works

Apolipoprotein E Peptide-Directed Chimeric Polymersomes Mediate an Ultrahigh-Efficiency Targeted Protein Therapy for Glioblastoma

Jiang, Y., Zhang, J., Meng, F., & Zhong, Z. (2018) · ACS Nano · doi:10.1021/acsnano.8b05265 · Cited by 201 · see citing works

Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System

Pattipeiluhu, R., Arias‐Alpizar, G., Basha, G., Chan, K. Y. T., Bussmann, J., Sharp, T. H., Moradi, M., Sommerdijk, N., Harris, E. N., Cullis, P. R., et al. (2022) · Advanced Materials · doi:10.1002/adma.202201095 · Cited by 194 · see citing works

Nanostructures: a platform for brain repair and augmentation

Vidu, R., Rahman, M., Mahmoudi, M., Enăchescu, M., Potecă, T. D., & Opriș, I. C. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00091 · Cited by 132 · see citing works

Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood–Brain Barrier

Chen, Z.-A., Wu, C. ‐., Wu, S., Huang, C.-Y., Mou, C., Wei, K., Yen, Y., Chien, I.-T., Runa, S., Chen, Y., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c08993 · Cited by 128 · see citing works

Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology

Moura, R. P., Martins, C., Pinto, S. F. T., Sousa, F., & Sarmento, B. F. C. C. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1583205 · Cited by 127 · see citing works

Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I

Gomez‐Ospina, N., Scharenberg, S. G., Mostrel, N., Bak, R. O., Mantri, S., Quadros, R. M., Gurumurthy, C. B., Lee, C. M., Bao, G., Suarez, C. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11962-8 · Cited by 119 · see citing works

LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases

Guo, Q., Zhu, Q., Miao, T., Tao, J., Ju, X., Sun, Z., Li, H., Xu, G., Chen, H., & Han, L. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.031 · Cited by 119 · see citing works

Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood–Brain Barrier (BBB)

Ghorai, S. M., Deep, A., Magoo, D., Gupta, C., & Gupta, N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071999 · Cited by 118 · see citing works

Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy

He, W., Li, X., Morsch, M., Ismail, M., Liu, Y., Rehman, F. U., Zhang, D., Wang, Y., Zheng, M., Chung, R. S., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c00320 · Cited by 116 · see citing works

Use of LDL receptor—targeting peptide vectors for in vitro and in vivo cargo transport across the blood‐brain barrier

Molino, Y., David, M., Varini, K., Jabès, F., Gaudin, N., Fortoul, A., Bakloul, K., Masse, M., Bernard, A., Drobecq, L., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600827r · Cited by 112 · see citing works

Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions

Nhàn, N. T. T., Yamada, T., & Yamada, K. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612931 · Cited by 109 · see citing works

Comparison of Five Peptide Vectors for Improved Brain Delivery of the Lysosomal Enzyme Arylsulfatase A

Böckenhoff, A., Cramer, S., Wölte, P., Knieling, S., Wohlenberg, C., Gieselmann, V., Galla, H., & Matzner, U. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4785-13.2014 · Cited by 103 · see citing works

Transportation of Single-Domain Antibodies through the Blood–Brain Barrier

Ruiz-López, E., & Schuhmacher, A. J. (2021) · Biomolecules · doi:10.3390/biom11081131 · Cited by 100 · see citing works

Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders

Salvalaio, M., Rigon, L., Belletti, D., D’Avanzo, F., Pederzoli, F., Ruozi, B., Marin, O., Vandelli, M. A., Forni, F., Scarpa, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156452 · Cited by 93 · see citing works

Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement

Hampe, C. S., Wesley, J. B., Lund, T. C., Orchard, P. J., Polgreen, L. E., Eisengart, J. B., McLoon, L. K., Cüreoğlu, S., Schachern, P. A., & McIvor, R. S. (2021) · Biomolecules · doi:10.3390/biom11020189 · Cited by 94 · see citing works

Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges

Parrasia, S., Szabó, I., Zoratti, M., & Biasutto, L. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00523 · Cited by 90 · see citing works

Brain‐targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms

Gleitz, H. F. E., Liao, A. Y., Cook, J. R., Rowlston, S., Forte, G. M. A., D’Souza, Z., O’Leary, C., Holley, R. J., & Bigger, B. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708730 · Cited by 85 · see citing works

Biomimetic drug-delivery systems for the management of brain diseases

Chen, Y., Wei, C., Lyu, Y., Chen, H., Jiang, G., & Gao, X. (2019) · Biomaterials Science · doi:10.1039/c9bm01395d · Cited by 86 · see citing works

Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis

Geraets, R. D., Koh, S. Y., Hastings, M. L., Kielian, T., Pearce, D. A., & Weimer, J. M. (2016) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0414-2 · Cited by 85 · see citing works

Concepts, technologies, and practices for drug delivery past the blood–brain barrier to the central nervous system

Crawford, L., Rosch, J. G., & Putnam, D. A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.041 · Cited by 83 · see citing works

Therapeutic potential of polypeptide-based conjugates: Rational design and analytical tools that can boost clinical translation

Melnyk, T., Đorđević, S., Conejos‐Sánchez, I., & Vicent, M. J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.007 · Cited by 80 · see citing works

The lncRNA H19 alleviates muscular dystrophy by stabilizing dystrophin

Zhang, Y., Li, Y., Hu, Q., Xi, Y. T., Xing, Z., Zhang, Z., Huang, L. A., Wu, J., Liang, K., Nguyen, T. K., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-00595-5 · Cited by 80 · see citing works

Treatment of brain disease in the mucopolysaccharidoses

Scarpa, M., Orchard, P. J., Schulz, A., Dickson, P., Haskins, M. E., Escolar, M. L., & Giugliani, R. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.10.007 · Cited by 72 · see citing works

CNS-Targeting Therapies for Lysosomal Storage Diseases: Current Advances and Challenges

Edelmann, M. J., & Maegawa, G. H. B. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.559804 · Cited by 64 · see citing works

1988–2018: Thirty years of drug smuggling at the nano scale. Challenges and opportunities of cell-penetrating peptides in biomedical research

Gallo, M., Defaus, S., & Andreu, D. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.11.010 · Cited by 64 · see citing works

The glycosylation design space for recombinant lysosomal replacement enzymes produced in CHO cells

Tian, W., Ye, Z., Wang, S., Schulz, M. A., Coillie, J. V., Sun, L., Chen, Y., Narimatsu, Y., Hansen, L. H., Kristensen, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09809-3 · Cited by 63 · see citing works

Lysosomal storage disease: Gene therapy on both sides of the blood–brain barrier

Aronovich, E. L., & Hackett, P. B. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.09.011 · Cited by 60 · see citing works

Delivery of Nanoparticles and Macromolecules across the Blood–Brain Barrier

Nowak, M., Helgeson, M. E., & Mitragotri, S. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900073 · Cited by 60 · see citing works

Branched BBB-shuttle peptides: chemoselective modification of proteins to enhance blood–brain barrier transport

Díaz‐Perlas, C., Oller‐Salvia, B., Sánchez‐Navarro, M., Teixidò, M., & Giralt, E. (2018) · Chemical Science · doi:10.1039/c8sc02415d · Cited by 59 · see citing works

Dual‐Targeted Novel Temozolomide Nanocapsules Encapsulating siPKM2 Inhibit Aerobic Glycolysis to Sensitize Glioblastoma to Chemotherapy

Zhang, Y., Ma, H., Li, L.-S., Sun, C., Yu, C., Wang, L., Xu, D., Song, X., & Yu, R. (2024) · Advanced Materials · doi:10.1002/adma.202400502 · Cited by 57 · see citing works

Blood–brain barrier peptide shuttles

Sánchez‐Navarro, M., Giralt, E., & Teixidò, M. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.04.019 · Cited by 57 · see citing works

A highly efficacious PS gene editing system corrects metabolic and neurological complications of mucopolysaccharidosis type I

Ou, L., Przybilla, M. J., Ahlat, O., Kim, S., Overn, P., Jarnes, J., O’Sullivan, M. G., & Whitley, C. B. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.03.018 · Cited by 56 · see citing works

Peptide Shuttles for Blood–Brain Barrier Drug Delivery

Sánchez‐Navarro, M., & Giralt, E. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091874 · Cited by 56 · see citing works

Setting-up an In Vitro Model of Rat Blood-brain Barrier (BBB): A Focus on BBB Impermeability and Receptor-mediated Transport

Molino, Y., Jabès, F., Lacassagne, E., Gaudin, N., & Khrestchatisky, M. (2014) · Journal of Visualized Experiments · doi:10.3791/51278 · Cited by 55 · see citing works

Targeting with nanoparticles for the therapeutic treatment of brain diseases

Jin, G., Chakraborty, A., Lee, J., Knowles, J. C., & Kim, H. (2020) · Journal of Tissue Engineering · doi:10.1177/2041731419897460 · Cited by 55 · see citing works

Nanobodies as modulators of inflammation: potential applications for acute brain injury

Rissiek, B., Koch‐Nolte, F., & Magnus, T. U. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00344 · Cited by 53 · see citing works

A novel gene editing system to treat both Tay–Sachs and sandhoff diseases

Ou, L., Przybilla, M. J., Tăbăran, A.-F., Overn, P., O’Sullivan, M. G., Jiang, X., Sidhu, R., Kell, P. J., Ory, D. S., & Whitley, C. B. (2020) · Gene Therapy · doi:10.1038/s41434-019-0120-5 · Cited by 52 · see citing works

Non-invasive PTEN mRNA brain delivery effectively mitigates growth of orthotopic glioblastoma

Liu, Y., Zhang, D., An, Y., Sun, Y., Li, J., Zheng, M., Zou, Y., & Shi, B. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101790 · Cited by 51 · see citing works

Effective Intravenous Therapy for Neurodegenerative Disease With a Therapeutic Enzyme and a Peptide That Mediates Delivery to the Brain

Meng, Y., Sohár, I., Sleat, D. E., Richardson, J. R., Reuhl, K. R., Jenkins, R. B., Sarkar, G., & Lobel, P. (2013) · Molecular Therapy · doi:10.1038/mt.2013.267 · Cited by 51 · see citing works

Polyethylene glycol-b-poly(lactic acid) Polymersomes As Vehicles for Enzyme Replacement Therapy

Kelly, J. M., Gross, A. L., Martin, D. R., & Byrne, M. E. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0221 · Cited by 49 · see citing works

Dendrimers as Effective Carriers for the Treatment of Brain Tumor

Gorain, B., Choudhury, H., Pandey, M., Amin, M. C. I. M., Singh, B., Gupta, U. D., & Kesharwani, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812218-1.00010-5 · Cited by 49 · see citing works

Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins

Pavani, G., Laurent, M., Fabiano, A., Cantelli, E., Sakkal, A., Corre, G., Lenting, P. J., Concordet, J., Toueille, M., Miccio, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17552-3 · Cited by 50 · see citing works

Oncoprotein Inhibitor Rigosertib Loaded in ApoE-Targeted Smart Polymersomes Reveals High Safety and Potency against Human Glioblastoma in Mice

Qin, H., Jiang, Y., Zhang, J., Deng, C., & Zhong, Z. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00691 · Cited by 49 · see citing works

Cancer research by means of tissue engineering – is there a rationale?

Horch, R. E., Boos, A. M., Quan, Y., Bleiziffer, O., Detsch, R., Boccaccini, A. R., Alexiou, C., Sun, J., Beier, J. P., & Arkudas, A. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12130 · Cited by 47 · see citing works

Delivering gene therapy for mucopolysaccharide diseases

Wood, S., & Bigger, B. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.965089 · Cited by 47 · see citing works

B3Pdb: an archive of blood–brain barrier-penetrating peptides

Kumar, V. D., Patiyal, S., Kumar, R., Sahai, S., Kaur, D., Lathwal, A., & Raghava, G. P. S. (2021) · Brain Structure and Function · doi:10.1007/s00429-021-02341-5 · Cited by 45 · see citing works

The interaction between particles and vascular endothelium in blood flow

Li, X., Zou, J., He, Z., Sun, Y., Song, X., & He, W. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115216 · Cited by 42 · see citing works

Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches

Firdaus, Z., & Li, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042320 · Cited by 43 · see citing works

Peptide based drug delivery systems to the brain

Islam, Y., Leach, A. G., Smith, J. A., Pluchino, S., Coxon, C. R., Sivakumaran, M., Downing, J. R., Fatokun, A. A., Teixidò, M., & Ehtezazi, T. (2020) · Nano Express · doi:10.1088/2632-959x/ab9008 · Cited by 40 · see citing works

Identification and characterization of Nanobodies targeting the EphA4 receptor

Schoonaert, L., Rué, L., Roucourt, B., Timmers, M., Little, S., Chávez‐Gutiérrez, L., Dewilde, M., Joyce, P. I., Curnock, A. P., Weber, P., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.774141 · Cited by 39 · see citing works

Neuronopathic lysosomal storage disorders: Approaches to treat the central nervous system

Scarpa, M., Bellettato, C. M., Lampe, C., & Begley, D. J. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.12.001 · Cited by 37 · see citing works

An overview of hypocretin based therapy in narcolepsy

Takenoshita, S., Sakai, N., Chiba, Y., Matsumura, M., Yamaguchi, M., & Nishino, S. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1459561 · Cited by 34 · see citing works

Nanobodies and Cancer: Current Status and New Perspectives

Allegra, A., Innao, V., Gerace, D. G., Vaddinelli, D., Allegra, A. G., & Musolino, C. (2018) · Cancer Investigation · doi:10.1080/07357907.2018.1458858 · Cited by 34 · see citing works

Apolipoprotein E Peptide-Guided Disulfide-Cross-Linked Micelles for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma

Li, Y., Wei, J., Wei, Y., Cheng, L., Guo, B., Meng, F., Li, F., & Zhong, Z. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b01419 · Cited by 34 · see citing works

Recent Strategies for Targeted Brain Drug Delivery

Ogawa, K., Kato, N., & Kawakami, S. (2020) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c20-00041 · Cited by 34 · see citing works

Development of an apolipoprotein E mimetic peptide–lipid conjugate for efficient brain delivery of liposomes

Kato, N., Yamada, S., Suzuki, R., Iida, Y., Matsumoto, M., Fumoto, S., Arima, H., Mukai, H., & Kawakami, S. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2173333 · Cited by 33 · see citing works

Phage display as a tool to discover blood–brain barrier ( BBB )‐shuttle peptides: panning against a human BBB cellular model

Díaz‐Perlas, C., Sánchez‐Navarro, M., Oller‐Salvia, B., Moreno, M. R., Teixidò, M., & Giralt, E. (2016) · Biopolymers · doi:10.1002/bip.22928 · Cited by 33 · see citing works

ApoE-modified liposomes encapsulating resveratrol and salidroside alleviate manifestations of Alzheimer’s disease in APP/PS-1 mice

Chen, M.-H., Liu, X., Qu, X., Guo, R., Zhang, L., Kong, L., Yu, Y., Liu, Y., Zang, J., Li, X., et al. (2023) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2023.2252062 · Cited by 32 · see citing works

Peptide Carrier-Mediated Non-Covalent Delivery of Unmodified Cisplatin, Methotrexate and Other Agents via Intravenous Route to the Brain

Sarkar, G., Curran, G. L., Sarkaria, J. N., Lowe, V. J., & Jenkins, R. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097655 · Cited by 32 · see citing works

Emerging therapies for neuropathic lysosomal storage disorders

Kelly, J. M., Bradbury, A. M., Martin, D. R., & Byrne, M. E. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.10.002 · Cited by 32 · see citing works

Beyond the Walls of Troy: A Scoping Review on Pharmacological Strategies to Enhance Drug Delivery Across the Blood–Brain Barrier and Blood–Tumor Barrier

Pinkiewicz, M., Zaczyński, A., Walecki, J. M., & Zawadzki, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157050 · Cited by 33 · see citing works

An Engineered Galactosylceramidase Construct Improves AAV Gene Therapy for Krabbe Disease in Twitcher Mice

Pan, X., Sands, S. A., Yue, Y., Zhang, K., LeVine, S. M., & Duan, D. (2019) · Human Gene Therapy · doi:10.1089/hum.2019.008 · Cited by 29 · see citing works

Endosomal escape cell-penetrating peptides significantly enhance pharmacological effectiveness and CNS activity of systemically administered antisense oligonucleotides

Dastpeyman, M., Sharifi, R., Amin, A., Karas, J. A., Cuic, B., Pan, Y., Nicolazzo, J. A., Turner, B. J., & Shabanpoor, F. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120398 · Cited by 28 · see citing works

Designing the future of nanomedicine: current barriers to targeted brain therapeutics

Herda, L. M., Polo, E., Kelly, P. M., Rocks, L., Hudecz, D., & Dawson, K. A. (2014) · European Journal of Nanomedicine · doi:10.1515/ejnm-2014-0022 · Cited by 30 · see citing works

Functional significance of gain-of-function H19 lncRNA in skeletal muscle differentiation and anti-obesity effects

Li, Y., Zhang, Y., Hu, Q., Egranov, S. D., Xing, Z., Zhang, Z., Liang, K., Ye, Y., Pan, Y., Chatterjee, S. S., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00937-4 · Cited by 27 · see citing works

Small, Smart, and LDLR-Specific Micelles Augment Sorafenib Therapy of Glioblastoma

Wei, J., Xia, Y., Meng, F., Ni, D., Qiu, X., & Zhong, Z. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c01103 · Cited by 27 · see citing works

Brain metastasis models: What should we aim to achieve better treatments?

Masmudi‐Martín, M., Zhu, L., Sánchez‐Navarro, M., Priego, N., Casanova-Acebes, M., Ruiz‐Rodado, V., Giralt, E., & Valiente, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.002 · Cited by 26 · see citing works

Loss of BRUCE reduces cellular energy level and induces autophagy by driving activation of the AMPK-ULK1 autophagic initiating axis

Che, L., Yang, X., Ge, C., El‐Amouri, S. S., Wang, Q.-E., Pan, D., Herzog, T. J., & Du, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216553 · Cited by 24 · see citing works

Efficient amyloid-β degradation in Alzheimer’s disease using SPYTACs

Teng, F., Liu, J., Cui, T., Tan, X., Liu, K., Hou, Z., (54356), L. Z., Xie, Y., Li, R., Li, D., et al. (2026) · Cell · doi:10.1016/j.cell.2026.01.034 · Cited by 24 · see citing works

Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier

Critchley, B. J., Gaspar, H. B., & Benedetti, S. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.11.015 · Cited by 23 · see citing works

RTB lectin-mediated delivery of lysosomal α-l-iduronidase mitigates disease manifestations systemically including the central nervous system

Ou, L., Przybilla, M. J., Koniar, B. L., & Whitley, C. B. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.11.013 · Cited by 23 · see citing works

Programmable DNA Nanodevices for Applications in Neuroscience

Hivare, P., Panda, C., Gupta, S. K., & Bhatia, D. D. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00723 · Cited by 21 · see citing works

Cell type-targeting nanoparticles in treating central nervous system diseases: Challenges and hopes

Guo, S., & Yi, C. (2023) · Nanotechnology Reviews · doi:10.1515/ntrev-2023-0158 · Cited by 22 · see citing works

Application prospect of peptide-modified nano targeting drug delivery system combined with PD-1/PD-L1 based immune checkpoint blockade in glioblastoma

Song, P., Zhao, X., & Xiao, S. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119865 · Cited by 21 · see citing works

Normalization and Improvement of CNS Deficits in Mice With Hurler Syndrome After Long-term Peripheral Delivery of BBB-targeted Iduronidase

El‐Amouri, S. S., Dai, M., Han, J., Brady, R. O., & Pan, D. (2014) · Molecular Therapy · doi:10.1038/mt.2014.152 · Cited by 21 · see citing works

Progression of Behavioral and CNS Deficits in a Viable Murine Model of Chronic Neuronopathic Gaucher Disease

Dai, M., Liou, B., Swope, B., Wang, X., Zhang, W., Inskeep, V., Grabowski, G. A., Sun, Y., & Pan, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162367 · Cited by 21 · see citing works

Identification and characterization of highly versatile peptide-vectors that bind non-competitively to the low-density lipoprotein receptor for in vivo targeting and delivery of small molecules and protein cargos

David, M., Lécorché, P., Masse, M., Faucon, A., Abouzid, K., Gaudin, N., Varini, K., Gassiot, F., Ferracci, G., Jacquot, G., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191052 · Cited by 21 · see citing works

Anchoring Microbubbles on Cerebrovascular Endothelium as a New Strategy Enabling Low‐Energy Ultrasound‐Assisted Delivery of Varisized Agents Across Blood‐Brain Barrier

Li, B., Lin, Y., Chen, G., Cai, M., Zhong, H., Xiao, Z., Lin, M., Li, T., Cai, Y., Shuai, X., et al. (2023) · Advanced Science · doi:10.1002/advs.202302134 · Cited by 20 · see citing works

Designing and Characterization of a Novel Delivery System for Improved Cellular Uptake by Brain Using Dendronised Apo-E-Derived Peptide

Al-azzawi, S., Masheta, D., Guildford, A. L., Phillips, G. J., & Santin, M. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00049 · Cited by 20 · see citing works

Efficient engraftment of genetically modified cells is necessary to ameliorate central nervous system involvement of murine model of mucopolysaccharidosis type II by hematopoietic stem cell targeted gene therapy

Miwa, S., Watabe, A. M., Shimada, Y., Higuchi, T., Kobayashi, H., Fukuda, T., Kato, F., Ida, H., & Ohashi, T. (2020) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2020.06.007 · Cited by 20 · see citing works

Hematopoietic Stem cell transplantation and lentiviral vector‐based gene therapy for Krabbe's disease: Present convictions and future prospects

Hu, P., Li, Y., Nikolaishvili‐Feinberg, N., Scesa, G., Bi, Y., Pan, D., Moore, D. T., Bongarzone, E. R., Sands, M. S., Miller, C. R., et al. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23847 · Cited by 19 · see citing works

Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?

Horgan, C., Jones, S. A., Bigger, B., & Wynn, R. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094854 · Cited by 18 · see citing works

Models to study basic and applied aspects of lysosomal storage disorders

Gaudioso, Á., Silva, T. P., & Ledesma, M. D. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114532 · Cited by 18 · see citing works

Single enzyme nanoparticle, an effective tool for enzyme replacement therapy

Kim, D. H., Lee, H. S., Kwon, T.-W., Han, Y.-M., Kang, N.-W., Lee, M. Y., Kim, D., Kim, M. G., & Lee, J. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01216-3 · Cited by 17 · see citing works

Hurdles in treating Hurler disease: potential routes to achieve a “real” cure

van den Broek, B. T. A., van Doorn, J., Hegeman, C. V., Nierkens, S., Lindemans, C. A., Verhoeven‐Duif, N. M., Boelens, J. J., & van Hasselt, P. M. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001708 · Cited by 17 · see citing works

Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe disease

Dogan, Y., Barese, C. N., Schindler, J. W., Yoon, J. K., Unnisa, Z., Guda, S., Jacobs, M. E., Oborski, C., Maiwald, T., Clarke, D. L., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.10.017 · Cited by 16 · see citing works

Brain-targeted multifunctional micelles delivering Oridonin and Phillyrin for synergistic therapy of Alzheimer's disease

Yu, Y., He, S.-Y., Kong, L., Shi, N.-N., Liu, Y., Zang, J., Guo, R., Zhang, L., Li, X., & Li, X. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104794 · Cited by 16 · see citing works

Understanding the In Vivo Fate of Advanced Materials by Imaging

Li, R., Ng, T. S. C., Garlin, M. A., Weissleder, R., & Miller, M. A. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910369 · Cited by 16 · see citing works

Platelets are efficient and protective depots for storage, distribution, and delivery of lysosomal enzyme in mice with Hurler Syndrome

Dai, M., Han, J., El‐Amouri, S. S., Brady, R. O., & Pan, D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323155111 · Cited by 16 · see citing works

miR-143 Regulates Lysosomal Enzyme Transport across the Blood-Brain Barrier and Transforms CNS Treatment for Mucopolysaccharidosis Type I

Lin, Y., Wang, X., Rose, K. P., Dai, M., Han, J., Xin, M., & Pan, D. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.06.011 · Cited by 15 · see citing works

Mucopolysaccharidoses and the blood–brain barrier

Sahin, O., Thompson, H. P., Goodman, G. W., Li, J., & Urayama, A. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00373-5 · Cited by 15 · see citing works

Characterization Of Blood–Brain Barrier Crossing And Tumor Homing Peptides By Molecular Dynamics Simulations

Arcangeli, C., Lico, C., Baschieri, S., & Mancuso, M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s225793 · Cited by 14 · see citing works

Brain delivery and activity of a lysosomal enzyme using a blood–brain barrier transport vehicle in mice

Ullman, J. C., Arguello, A., Getz, J. A., Bhalla, A., Mahon, C. S., Wang, J., Giese, T., Bedard, C., Kim, D. J., Blumenfeld, J. R., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay1163 · Cited by 205 · see citing works

Improved brain uptake and efficacy of iduronate 2-sulfatase with the enzyme transport vehicle

Henry, A. G., Kariolis, M. S., Ullman, J. C., Getz, J. A., Arguello, A., Mahon, C. S., Wang, J., Bhalla, A., Giese, T., Bédard, C., et al. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.12.174 · Cited by 1 · see citing works

Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood‐brain barrier

Boado, R. J., Zhang, Y., Zhang, Y., Xia, C., Wang, Y., & Pardridge, W. M. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21602 · Cited by 142 · see citing works

Comparison of Five Peptide Vectors for Improved Brain Delivery of the Lysosomal Enzyme Arylsulfatase A

Böckenhoff, A., Cramer, S., Wölte, P., Knieling, S., Wohlenberg, C., Gieselmann, V., Galla, H., & Matzner, U. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4785-13.2014 · Cited by 103 · see citing works

Non-clinical evaluation of a blood-brain barrier-penetrating enzyme for the treatment of mucopolysaccharidosis type I

Kida, S., Kinoshita, M., Tanaka, S., Okumura, M., Koshimura, Y., & Morimoto, H. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.12.205 · Cited by 5 · see citing works